Your browser doesn't support javascript.
loading
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
Kristoffersson, A N; Rognås, V; Brill, M J E; Dishon-Benattar, Y; Durante-Mangoni, E; Daitch, V; Skiada, A; Lellouche, J; Nutman, A; Kotsaki, A; Andini, R; Eliakim-Raz, N; Bitterman, R; Antoniadou, A; Karlsson, M O; Theuretzbacher, U; Leibovici, L; Daikos, G L; Mouton, J W; Carmeli, Y; Paul, M; Friberg, L E.
  • Kristoffersson AN; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Rognås V; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Brill MJE; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Dishon-Benattar Y; Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel; The Cheryl Spencer Institute for Nursing Research, University of Haifa, Israel.
  • Durante-Mangoni E; Department of Precision Medicine, University of Campania 'L Vanvitelli' and AORN dei Colli-Monaldi Hospital, Napoli, Italy.
  • Daitch V; Infectious Diseases University Research Centre, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, and Department of Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel.
  • Skiada A; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Lellouche J; National Centre for Infection Control and Antibiotic Resistance, Tel Aviv Medical Centre, Tel Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, Tel Aviv Medical Centre, Tel Aviv, Israel.
  • Nutman A; National Centre for Infection Control and Antibiotic Resistance, Tel Aviv Medical Centre, Tel Aviv, Israel.
  • Kotsaki A; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, University General Hospital Attikon, Athens, Greece.
  • Andini R; Department of Precision Medicine, University of Campania 'L Vanvitelli' and AORN dei Colli-Monaldi Hospital, Napoli, Italy.
  • Eliakim-Raz N; Infectious Diseases University Research Centre, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, and Department of Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel.
  • Bitterman R; Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Techion - Israel Institute of Technology, Haifa, Israel.
  • Antoniadou A; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, University General Hospital Attikon, Athens, Greece.
  • Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Theuretzbacher U; Centre for Anti-Infective Agents, Vienna, Austria.
  • Leibovici L; Sackler Faculty of Medicine, Tel-Aviv University, and Department of Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel; Department of Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel.
  • Daikos GL; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Mouton JW; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlands.
  • Carmeli Y; National Centre for Infection Control and Antibiotic Resistance, Tel Aviv Medical Centre, Tel Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, Tel Aviv Medical Centre, Tel Aviv, Israel.
  • Paul M; Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Techion - Israel Institute of Technology, Haifa, Israel.
  • Friberg LE; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. Electronic address: lena.friberg@farmbio.uu.se.
Clin Microbiol Infect ; 26(12): 1644-1650, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32213316
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Colistina / Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Colistina / Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article